Both oxygen free radicals and excitatory amino acids have been implicated as important cellular toxins in ischemic brain. Recent in vitro studies suggest that there may be a mutual interaction between these two mediators. We explored the relation between oxygen free radicals and excitatory amino acids in the development of ischemic brain edema in vivo. Male Sprague-Dawley rats were treated with the free radical scavenger dimethylthiourea 1 hour before ischemia or with the excitotoxin antagonist MK-801 30 minutes before ischemia produced by occlusion of the middle cerebral artery. Groups of seven or eight animals were treated with vehicle, low-dose (375 mg/kg) dimethylthiourea, high-dose (750 nig/kg) dimethylthiourea, low-dose (0.5 mg/kg) MK-801, high-dose (2.0 mg/kg) MK-801, or both high-dose dimethylthiourea and low-dose MK-801. After 4 hours of ischemia, brain water content was determined. In eight vehicle-treated controls, mean±SEM water content of tissue in the center of the ischemic zone was 83.29±0.18%. A significant reduction of brain edema was observed in all drug-treated groups: for example, 50.2% (p<0.001) in the high-dose dimethylthiourea group, 53.7% (p<0.001) in the low-dose MK-801 group, and 66.4% (/?<0.001) in the combined dimethylthiourea and MK-801 group. Combined treatment with dimethylthiourea and MK-801 provided no significant additive effect over that resulting from treatment with MK-801 alone. These results indicate that pretreatment with either dimethylthiourea or MK-801 can reduce brain edema during the early stages of cerebral ischemia and further suggest that excitatory amino acids and oxygen free radicals may damage the brain by a common pathway. Supported by a grant-in-aid from the American Heart Association of Michigan.
R ecent studies have implicated oxygen free radicals as toxic intermediates in ischemic brain injury 1 " 11 ; however, the principal sources of the free radicals and the mechanisms by which these toxic oxygen species damage brain tissue have not been identified. At the same time, there is increasing evidence that excitatory amino acids such as glutamate and aspartate play an important role as mediators of brain injury during cerebral ischemia. Increased release of excitatory amino acids has been reported during cerebral ischemia in vivo 12 " 15 and during simulated ischemic conditions in vitro. 16 " 18 A number of in vitro and in vivo experimental studies have shown that excitatory amino acid receptor antagonists have a protective effect on brain following cerebral ischemia. 19 -28 One putative source of oxygen free radicals during cerebral ischemia is the arachidonic acid cascade. 29 " 31 Since the activation of excitatory neurotransmitter receptors leads to the release of arachidonic acid, 32 excitatory amino acids could theoretically cause the generation of oxygen free radicals by this mechanism during cerebral ischemia. In support of this hypothesis, oxygen free radical quenchers or lipid peroxidation inhibitors were recently shown to reduce excitatory amino acid-induced neuronal injury in vitro. 33 - 34 Other recent reports suggest that oxygen free radicals can themselves cause excitatory amino acid release. PellegriniGiampietro et al 35 reported that oxygen free radicals generated from xanthine-xanthine oxidase stimulated the release of excitatory amino acids from rat hippocampal slices. Furthermore, in an in vitro ischemic model, oxygen free radical quenchers prevented the release of excitatory amino acids. 36 Thus, it is very likely that a causal relation or a cooperation exists between these two important in-jury mechanisms during ischemia; however, there are no reports concerning the relation between oxygen free radicals and excitatory amino acids in animal models of ischemia. To explore the roles of oxygen free radicals and excitotoxins in producing brain edema during incomplete cerebral ischemia, we treated rats with l,3-dimethyl-2-thiourea (DMTU), a hydrogen peroxide and hydroxyl radical scavenger, and with (+)-5-methyl-10,ll-dihydro-5//-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801), a noncompetitive /V-methyl-D-aspartate (NMDA) receptor inhibitor. 37 ' 38 We compared the effect of combined treatment with both DMTU and MK-801 and the effect of treatment with either DMTU or MK-801 alone on ischemic brain edema formation during incomplete cerebral ischemia.
Materials and Methods
Sprague-Dawley rats were obtained from Charles River, Portage, Mich.; DMTU was obtained from Aldrich Chemical Co., Milwaukee, Wis.; and MK-801 was a kind gift from Dr. P. Anderson, Merck & Co., Inc., West Point, Pa.
We used 46 male rats weighing 350-450 g. The animals were given free access to food and water before anesthesia. They were anesthetized with 2% halothane through a mask, 39 and a tracheotomy was performed. Thereafter, anesthesia was maintained by spontaneous respiration with the delivery of 0.5-1.0% halothane in a mixture of room air and oxygen through a tracheal cannula. Catheters were placed in a femoral vein for the administration of drugs and a femoral artery for the monitoring of mean blood pressure, blood gases, hematocrit, plasma osmolality, blood glucose, and serum electrolytes. Body temperature was monitored by a rectal thermometer, and the temperature of the head was monitored by a thermocouple placed in the temporalis muscle. This served as an indirect estimation of brain temperature. 40 By using an external heating pad and a heat lamp, the body temperature and head temperature were maintained within a normal physiological range. Blood gases were checked before and at the time of middle cerebral artery occlusion (MCAO) and then every hour during ischemia.
After stabilization of blood gases, an incision was made midway between the right eye and ear, the temporal fascia was incised, and the muscle was separated along the plane of its fibers. The zygoma was cut near its posterior attachment to the skull, and a 10-mm-diameter craniectomy was performed. The dura was incised, and the arachnoidea adjacent to the middle cerebral artery was removed. A 5-7-mm length of the middle cerebral artery was cauterized from 2-3 mm proximal to the olfactory tract to the inferior cerebral vein as described by Bederson et al. 41 The rats were decapitated 4 hours after MCAO. The brains were quickly removed, the cerebral hemispheres were divided, and the subcortical structures were discarded. The remaining cortical shells from the ischemic and nonischemic hemispheres were placed flat and then divided into three samples using 7-and 10-mm cork borers. The central zone was taken from the lateral cortex directly underlying the initial occluded portion of middle cerebral artery using the 7-mm cork borer. The intermediate zone was a 10-mm-diameter ring of tissue surrounding the center, while the outer zone consisted of the remaining cortical tissue. 942 In a previous study using ketamine/xylazine-anesthetized rats, cerebral blood flow was found to average 17 ml/100 g/min in the center zone, 26 ml/100 g/min in the intermediate zone, and 44 ml/100 g/min in the outer zone after 4 hours of ischemia. 9 The rats were divided into six groups: eight were treated with vehicle, seven with 375 mg/kg DMTU, eight with 750 mg/kg DMTU, eight with 0.5 mg/kg MK-801, seven with 2.0 mg/kg MK-801, and eight with both 750 mg/kg DMTU and 0.5 mg/kg MK-801. Since our previous experimental results showed that the water content of the nonischemic hemisphere was identical to that in sham-operated control rats, 9 ' 11 in the present study the sham-operated control group was omitted.
The DMTU was given intraperitoneally 1 hour before MCAO whereas the MK-801 was given intravenously 30 minutes before MCAO. To have comparable treatments and to facilitate comparison between groups, all animals received both intraperitoneal and intravenous injections of either a drug or the saline vehicle. The control group received 7.5 ml/kg i.p. saline and 1 ml/kg i.v. saline. Drug-treated rats received the same volumes.
To measure the water and ion contents, brain samples were placed in preweighed crucibles, weighed, dried for 24 hours at 100°C, and then weighed again. The percentage water of the brain tissue was calculated from the difference between the wet and dry weights. The dried brain samples were subsequently ashed in a muffle oven at 400°C for 16 hours. The residues were dissolved in 7 ml water, and the sodium and potassium contents were determined by flame photometry with cesium as the internal standard.
All data are reported as mean ± standard error of the mean. Differences between groups were identified using analysis of variance, and the level of significance of the differences was determined using Fisher's protected least significant difference test for multiple comparisons. Samples from ischemic and nonischemic hemispheres within the same treatment group were compared using Student's t test for paired samples.
Results
Values for the physiological parameters obtained during the ischemic period from all rats in the six groups are given in Table 1 . In a pilot study, no significant differences were observed during the ischemic period in the values of hematocrit, blood glucose, plasma osmolality, plasma sodium, and plasma potassium; therefore, they were checked only once, at the time of MCAO. All physiological parameters were within normal limits during the ischemic period in all experimental groups; however, mean blood pressure, PaOj, plasma osmolality, and plasma sodium showed significant differences between groups. These differences were small and unlikely to have had an effect on the results. The cause of the elevation of mean blood pressure in the MK-801-treated groups was thought to be due to the central sympathomimetic activity of the drug 25 -43 and the relatively light halothane anesthesia in those groups to avoid respiratory depression resulting from the deep sedative effect of MK-801. Figure 1 shows the water content in the three zones of both hemispheres of the six experimental groups, and Figure 2 shows the change in water content calculated from the difference between the water contents in the three zones of the ischemic and nonischemic cortices. In the control group, brain water content was significantly increased to 83.29±0.18%, 80.84+0.24%, and 79.68±0. 42 except for the slightly higher water content in the nonischemic hemisphere. This small change in the present study might be due to the intraperitoneal saline injection and the increased intravenous administration of saline as a replacement for blood volume removed for frequent blood gas determinations.
All five drug-treated groups showed significantly less brain edema in the central zone than the control group (31.6% in the low DMTU group, 50.2% in the high DMTU group, 53.7% in the low MK-801 group, 57.3% in the high MK-801 group, and 66.4% in the combined group; p<0.001 for all groups). In the intermediate zone, all drug-treated groups except the low DMTU group also showed significant reductions in brain edema. However, in the outer zone, where edema was relatively minor, only the low MK-801 and combined groups showed significant reductions in brain edema. DMTU and MK-801 had essentially no significant effect on the water content of the nonischemic hemispheres.
Between the low DMTU group and the high DMTU group, the latter showed a greater reduction in brain edema than the former in the central zone (p<0.05). This finding suggests that the dose of DMTU used in the high DMTU group might not have been a maximally effective dose. Therefore, we tried three higher doses of DMTU (3.0 g/kg, 1.5 g/kg, and 1.025 g/kg) in a pilot study, but all experimental animals died or showed severe hypotension for several hours after the intraperitoneal injection of these higher doses of DMTU. Between the low MK-801 group and the high MK-801 group, no significant difference was observed in the effect on brain edema. This result agrees with other reports indicating that 0.5 mg/kg MK-801 provides maximally effective NMD A receptor antagonism for several hours after intravenous injection. 2344 Consequently, we used a low dose of MK-801 in the combined DMTU and MK-801 treatment group to avoid the potential toxic effects of a high dose of MK-801.
FIGURE 1. Water content in three zones of ischemic (hatched bar) and nonischemic (filled bar) cortices 4 hours
The combined DMTU and MK-801 group showed significant reductions in brain edema in the central and intermediate zones (p<0.05) compared with the high DMTU group. However, combined therapy did not significantly reduce brain edema compared with the low MK-801 group. Accordingly, there was no significant additive protective effect of DMTU and MK-801 on the development of ischemic brain edema over 4 hours in this rat MCAO model.
As reported previously, the development of brain edema following MCAO in rats is associated with a net increase in the sodium content and a net decrease in the potassium content of the brain ( Table 2 ). The magnitude of these changes is proportional to the amount of edema that develops and, therefore, the changes were greatest in the central zone and least in the outer zone. In general, the effects of the drug treatments on the change in ion contents were similar to their effects on brain edema. Thus, both doses of DMTU and both doses of MK-801 significantly reduced the increase in sodium content and the decrease in potassium content in the central and intermediate zones (Table 2) . Although the high DMTU group showed significantly smaller changes in the central zone than the low DMTU group, the high MK-801 group was not different from the low MK-801 nonischemic cortex using two-tailed paired / test. using analysis of variance and Fisher's projected least significant difference group. Finally, combined treatment did not afford a greater effect than treatment with either agent alone. Discussion A number of recent studies using a variety of approaches have shown that both free radicals and excitatory amino acids contribute to brain injury during incomplete cerebral ischemia.
14 -58 - 11 ' 25 The purpose of the present study was to investigate the relation between these two important reactions. For that purpose we chose DMTU as a free radical quencher since it is a potent hydrogen peroxide and hydroxyl radical scavenger, it is lipid soluble and enters the brain easily, and it has a relatively long serum half-life. 4546 We chose MK-801 as an excitatory amino acid receptor inhibitor since it is a potent, selective, noncompetitive antagonist of the NMDA receptor and it has high use dependence, high lipid solubility, and a long serum half-life.
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Our DMTU-and MK-801-treated groups showed significant reductions in brain edema compared with the vehicle-treated group. These results indicate indirectly that free radical-and excitotoxin-mediated reactions participate in the formation of ischemic brain edema during permanent, incomplete cerebral ischemia. However, combined therapy with DMTU and MK-801 showed no significant additive reduction of brain edema over therapy with MK-801 alone. Since the NMDA receptor has a major role in excitotoxininduced brain injury and since the low dose of MK-801 blocks this receptor completely, the lack of a significant additive effect in this study suggests that the majority of the oxygen free radicals scavenged by DMTU may be generated by an excitatory amino acid-mediated reaction. Furthermore, a large portion of the brain edema caused by excitatory amino acid release in the ischemic hemisphere has a close relation to free radicals. A less likely explanation for the lack of an additive effect is that free radicals and excitatory amino acids cause cells to swell by independent mechanisms and that this can be prevented by either of the pharmacological treatments.
Previous studies have suggested that the protective effect of MK-801 is largely mediated through the hypothermia that it induces. 48 We maintained the body temperature and head temperature within a normal physiological range in all groups; therefore, the protective effect of MK-801 on brain edema in this model of permanent incomplete cerebral ischemia was not considered to be due to an effect on body temperature. We cannot exclude the possibilities that MK-801 acts as a free radical scavenger or that DMTU interacts directly with NMDA receptors. These possibilities, however, seem unlikely.
The DMTU used in this study may not have resulted in maximal scavenging of all types of oxygen free radicals since DMTU does not quench superoxide radicals or singlet oxygen. Thus, some free radicals might have escaped quenching, and this may explain why the combined DMTU and MK-801 therapy had a greater effect on edema in the central zone than did therapy with DMTU alone.
The mechanism of excitatory amino acid neurotoxicity in vivo is not fully understood at present, but two different mechanisms proposed by Rothman and Olney 4749 on the basis of in vitro studies are generally considered. The first mechanism involves osmotic damage as a direct consequence of excitatory depolarization. The second mechanism is calcium-mediated, and the NMDA subtype of glutamate receptor plays a predominant role. Between them, the calcium-mediated mechanism resembles the neuropathology of ischemic neuronal injury and is considered more important in excitatory amino acid neurotoxicity. 50 - 52 As a result of calcium entry into cells, oxygen free radicals could be generated through a release of arachidonic acid following the activation of phospholipase A 2 . 32 Evidence for the generation of oxygen free radicals by an excitatory amino acid-mediated reaction has recently been reported. Using an in vitro ischemic model of cultured brain cortical cells, Monyer et al 34 showed that the novel antioxidant 21-aminosteroid attenuated neuronal damage, but to a lesser degree than the protective effect of an NMDA receptor antagonist. Moreover, 21-aminosteroids reduced excitatory amino acid-induced neuronal injury. Therefore, these authors suggested that free radical-induced lipid peroxidation may, at least in part, occur subsequent to overstimulation of NMDA receptors. That in vitro study supports our present in vivo study, which indicates that an excitatory amino acid-mediated reaction may be a major source of oxygen free radicals in permanent incomplete cerebral ischemia.
Other recent reports suggest that an excitatory amino acid-mediated process and a free radical reaction could cooperate in the genesis of ischemic neuronal injury in another way. Pellegrini-Giampietro et al 35 -36 showed that exogenously generated free radicals increase the release of excitatory amino acids from rat hippocampal slices. Moreover, the increase of excitatory amino acid release from rat hippocampal slices in an in vitro ischemic model was markedly reduced by various drugs that scavenged or reduced the production of oxygen free radicals. These authors suggested that a "vicious cycle" of excitatory amino acid release after the activation of NMDA receptors by excitatory amino acids is mediated by oxygen free radicals.
While further study will be needed to explore the mechanisms by which free radicals and excitatory amino acids produce brain edema during incomplete cerebral ischemia, our results strongly support the idea that these two mechanisms of brain injury are related.
